DLAT and primary biliary cholangitis: PDC-E2, the hallmark antigen of PBC, induces anti-mitochondrial antibodies (AMA) that cross-react with Novosphingobium aromaticivorans, which are conditioned by the disruption of the intestinal barrier and the increase in permeability that occurs in inflammatory bowel diseases (32).